ME2C Environmental Reports Fourth Quarter and Full Year 2022 Results, Achieves 66% Revenue Growth YoY
Significant Revenue Increase Promotes the Company’s Expansion into New Markets & Technologies Corsicana, Texas–(Newsfile Corp….
Significant Revenue Increase Promotes the Company’s Expansion into New Markets & Technologies Corsicana, Texas–(Newsfile Corp….
Enhanced offering automates reconciliation across banks and third-party credit card processors LAS VEGAS–(BUSINESS WIRE)–Nacha Smarter…
Vancouver, British Columbia–(Newsfile Corp. – April 17, 2023) – Hypercharge Networks Corp. (NEO: HC) (OTCQB: HCNWF) (FSE:…
Outlines Corporate Vision and Discusses Ongoing Restructuring to Enhance Operational Efficiency Reports Annualized Cost Reductions Anticipated…
HONG KONG, Apr 17, 2023 – (ACN Newswire) – Endurance RP Limited (“Endurance” or the…
SINGAPORE, Apr 17, 2023 – (ACN Newswire) – EveLab Insight, a leading provider of AI-driven…
New proprietary monitoring devices can help the 157 Million US Adults suffering from chronic conditions,…
Lenovo And Dallas Cowboys Multi-Year Partnership Brings Cutting-Edge Hardware Technology to Dallas Cowboys Organization Cowboys…
Erinn King joins the Boston-based fixed income manager to drive the firm’s growth strategy and…
Nicholas Holmes appointed portfolio manager and senior analyst CHICAGO–(BUSINESS WIRE)–Duff & Phelps Investment Management Co.,…
Preclinical data supports targeting ITK as a new approach for cancer immunotherapy Novel mechanism of…
Preclinical data supports targeting ITK as a new approach for cancer immunotherapy Novel mechanism of…
Data suggest Cyclin E1 plays a critical role in high proportion of multiple tumor types…
Data suggest Cyclin E1 plays a critical role in high proportion of multiple tumor types…
Hutrukin, A Therapy Discovered and Manufactured at XBiotech, Is Aimed to Reduce Brain Injury after…
Hutrukin, A Therapy Discovered and Manufactured at XBiotech, Is Aimed to Reduce Brain Injury after…
Preclinical data describes a novel EGFR-sparing, brain-penetrant ErbB2 inhibitor active against key oncogenic ErbB2 mutations…
Preclinical data describes a novel EGFR-sparing, brain-penetrant ErbB2 inhibitor active against key oncogenic ErbB2 mutations…
Media Release Soft tissue sarcoma, an orphan disease, represents a high unmet medical need with…
Media Release Soft tissue sarcoma, an orphan disease, represents a high unmet medical need with…